Position
Squarepoint Ops LLC in Moonlake Immunotherapeutics
Back to the book · All holders of MLTX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $601.8K$13.18 → $18.64
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 121.6K | $1.6M | — | — | — | 0.0% |
| Q1 2026 | 110.2K | $2.05M | $18.64 | $601.8K | −$150.6K | 0.0% |